| GeneLibs

题目:: The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells.
作者:: Sanberg(Paul R),Eve(David J),Willing(Alison E),Garbuzova-Davis(Svitlana),Tan(Jun),Sanberg(Cyndy D),Allickson(Julie G),Cruz(L Eduardo),Borlongan(Cesar V)
状态:: 发布时间2011-03-14 , 更新时间 2011-03-14
期刊:: Cell Transplant
摘要:: Stem cell transplantation is a potentially important means of treatment for a number of disorders. Two different stem cell populations of interest are mononuclear umbilical cord blood cells and menstrual blood-derived stem cells. These cells are relatively easy to obtain, appear to be pluripotent, and are immunologically immature. These cells, particularly umbilical cord blood cells, have been studied as either single or multiple injections in a number of animal models of neurodegenerative disorders with some degree of success, including stroke, Alzheimer's disease, amyotrophic lateral sclerosis, and Sanfilippo syndrome type B. Evidence of anti-inflammatory effects and secretion of specific cytokines and growth factors that promote cell survival, rather than cell replacement, have been detected in both transplanted cells.
语言:: eng
DOI:: 10.3727/096368910X532855

文献库文献相关信息